About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Global - Contact
Investor Contact
Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com
SEC Filings
Filing date | Form | Description | Filing Group | View |
---|---|---|---|---|
D |
Other
|
View HTML | ||
S-1 | Registration statement for face-amount certificate companies |
Registration Statements
|
View HTML | |
S-1/A | Amended Registration statement for face-amount certificate companies |
Registration Statements
|
View HTML | |
8-A12B | Registration of certain classes of securities 12(b) of the Securities Exchange Act |
Registration Statements
|
View HTML | |
CT ORDER | CT ORDER |
Other
|
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
3,4,5
|
View HTML |
Data provided by Kaleidoscope.
Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Investor Contact
Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com